These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36548203)

  • 21. Diabetic ketoacidosis and mortality in COVID-19 infection.
    Stevens JS; Bogun MM; McMahon DJ; Zucker J; Kurlansky P; Mohan S; Yin MT; Nickolas TL; Pajvani UB
    Diabetes Metab; 2021 Nov; 47(6):101267. PubMed ID: 34332112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt.
    Sherif EM; Elhenawy YI; Matter RM; Aly HH; Thabet RA; Fereig YA
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):925-936. PubMed ID: 33882200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Alomari MA; Al Salman SA; Al-Alawi AS; Al Hassan MH; Alhamad H; Al-Kamees MA; Almousa FM; Mufti HN; Alwesabai AM; Dhama K; Al-Tawfiq JA; Al-Omari A
    Diabetol Metab Syndr; 2021 Oct; 13(1):120. PubMed ID: 34702335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with the presence of diabetic ketoacidosis: A retrospective analysis of patients with type 1 diabetes in Saudi Arabia.
    Al Hayek AA; Robert AA; Al-Shaikh R; Alhojele M; Aloufi S; Sabri D; Alenazi M; Hassan AH; Al Dawish M
    Diabetes Metab Syndr; 2020; 14(6):2117-2122. PubMed ID: 33395771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic.
    Chao LC; Vidmar AP; Georgia S
    Diabetes Care; 2021 Jun; 44(6):1451-1453. PubMed ID: 33905347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New-Onset Type 1 Diabetes in Children With SARS-CoV-2 Infection.
    Ambati S; Mihic M; Rosario DC; Sanchez J; Bakar A
    Cureus; 2022 Mar; 14(3):e22790. PubMed ID: 35382205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea.
    Han MJ; Heo JH
    Diabetes Metab Syndr Obes; 2021; 14():783-790. PubMed ID: 33654417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series.
    Alsadhan I; Alruwashid S; Alhamad M; Alajmi S; Alshehri S; Alfadhli E; Ekhzaimy A
    Curr Ther Res Clin Exp; 2020; 93():100609. PubMed ID: 33132404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase in newly diagnosed type 1 diabetes and serological evidence of recent SARS-CoV-2 infection: Is there a connection?
    Denina M; Trada M; Tinti D; Funiciello E; Novara C; Moretto M; Rosati S; Garazzino S; Bondone C; De Sanctis L
    Front Med (Lausanne); 2022; 9():927099. PubMed ID: 35966867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic ketoacidosis and COVID-19: what have we learned so far?
    de Sá-Ferreira CO; da Costa CHM; Guimarães JCW; Sampaio NS; Silva LML; de Mascarenhas LP; Rodrigues NG; Dos Santos TL; Campos S; Young EC
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E44-E53. PubMed ID: 34779657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients.
    Mondal S; DasGupta R; Lodh M; Gorai R; Choudhury B; Hazra AK; Ganguly A
    Diabetes Metab Syndr; 2021; 15(3):795-801. PubMed ID: 33839639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic Ketoacidosis in Coronavirus Disease Patients With Type 2 Diabetes Mellitus.
    Winn SP; Oo ZT; Htun NN; Soe MHP; Aung MM
    Cureus; 2020 Aug; 12(8):e9731. PubMed ID: 32953287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases.
    Suwanwongse K; Shabarek N
    J Med Virol; 2021 Feb; 93(2):1150-1153. PubMed ID: 32706395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Perfect Storm: Rapid Progression of Diabetic Ketoacidosis in Pediatric Diabetes in the Setting of COVID-19.
    Modarelli R; Balikcioglu PG; Hendrix G; DeRusso M; Ozment C
    AACE Clin Case Rep; 2021; 7(6):357-359. PubMed ID: 34104714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final-year medical students' awareness and knowledge about DKA: A cross-sectional study from a Saudi University.
    Madkhly TM; Mohammed FA; Majrashi HH; Kamili FH; Tawhari RAM; Hudisy AA; AbuDyab OAM; Mohajab AHA; Tumayhi GM
    J Family Med Prim Care; 2020 Feb; 9(2):1076-1079. PubMed ID: 32318470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
    Chan KH; Thimmareddygari D; Ramahi A; Atallah L; Baranetsky NG; Slim J
    Diabetes Res Clin Pract; 2020 Aug; 166():108279. PubMed ID: 32592843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience.
    Abdou M; Hassan MM; Hassanein SA; Elsebaie EH; Shamma RA
    Front Endocrinol (Lausanne); 2022; 13():814991. PubMed ID: 35360079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.
    Gupta RD; Atri A; Mondal S; Bhattacharjee A; Garai R; Hazra AK; Choudhury B; Dutta DS; Lodh M; Ganguly A
    J Diabetes Complications; 2022 Mar; 36(3):108100. PubMed ID: 34916147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19.
    Morrison N; Barnett K; Tantum J; Morrison HK; Whalen M
    Cureus; 2020 Dec; 12(12):e12029. PubMed ID: 33457131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.